With the rise of advanced eye care technology, retinal imaging devices are becoming more important for detecting and managing diseases such as glaucoma, macular degeneration, and diabetic retinopathy. While these devices bring innovation to clinics and hospitals, I’m curious about the challenges that retinal imaging device manufacturers face in terms of production, regulations, and global accessibility. What are the major hurdles they deal with, and how do they continue to innovate despite them?